NCT05478239View on ClinicalTrials.gov

ArtemiCoffee in Patients With Rising PSA

PHASE2RecruitingINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

August 11, 2023

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions

Prostate Cancer

Interventions

DRUG

ArtemiCoffee

3 cups of Artemisia annua (Aa) coffee per day (1350mg) for 24 weeks.

Trial Locations (1)

40536

RECRUITING

University of Kentucky, Lexington

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

ArtemiLife

UNKNOWN

lead

Zin W Myint

OTHER